{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:49:40Z","timestamp":1782103780074,"version":"3.54.5"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Helicobacter pylori<\/jats:italic>\n                      (HP) infection has been increasingly linked to metabolic dysfunction-associated steatotic liver disease (MASLD). However, evidence remains inconsistent, and the predictive value of HP status within integrated risk models is unclear. This study aimed to evaluate the association between HP infection and MASLD and to develop interpretable machine learning models for MASLD risk stratification.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 1,021 participants from a Chinese hospital-based cohort and 4,870 participants from the U.S. National Health and Nutrition Examination Survey (NHANES 1999\u20132000) were included. In the Chinese cohort, active HP infection was assessed using the 13C or 14C-urea breath test, and MASLD was diagnosed by ultrasonography. In NHANES, HP exposure was defined by serum IgG seropositivity, and MASLD was approximated using the Fatty Liver Index (FLI). Logistic regression was used to assess the association between HP and MASLD. Mediation analysis was conducted to explore potential metabolic and inflammatory pathways. Eleven machine learning models were developed in the Chinese cohort and evaluated using ROC, calibration, and SHAP analysis, with external comparison in NHANES using a reduced feature set to minimize potential bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the Chinese cohort, HP infection was significantly associated with MASLD in crude (OR\u202f=\u202f7.11), age- and sex-adjusted (OR\u202f=\u202f6.48), and further adjusted models (including diabetes, cholesterolemia, and BMI; OR\u202f=\u202f4.83, 95% CI: 3.07\u20137.23,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001). This elevated OR should be interpreted as cohort-specific and not generalizable. A positive association was also observed in NHANES (adjusted OR\u202f=\u202f1.22, 95% CI: 1.14\u20131.59,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.017). Machine learning models demonstrated strong internal performance (AUC up to 0.8876), while external comparison in NHANES showed moderate discrimination (best AUC\u202f=\u202f0.6536). SHAP analysis identified HP and LHR as the top contributors to MASLD prediction, with TyG-related indices showing secondary importance. Mediation analysis suggested potential involvement of metabolic and inflammatory indices, although these findings should be interpreted as exploratory.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HP infection was associated with MASLD in both Chinese and U.S. populations. Interpretable machine learning models demonstrated potential for MASLD risk stratification, with consistent identification of key predictors across cohorts. However, due to cross-sectional design, differences in diagnostic definitions, and the use of FLI in NHANES, findings should be interpreted as associative rather than causal, and external validation results should be considered exploratory.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1730461","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:34:20Z","timestamp":1782102860000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between Helicobacter pylori infection and MASLD: a cross-sectional study with interpretable machine learning for MASLD risk prediction"],"prefix":"10.3389","volume":"13","author":[{"given":"Yue","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Digestive Endoscopy Center, The Second Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifeng","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Digestive Endoscopy Center, The Second Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Digestive Endoscopy Center, The Second Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Digestive Endoscopy Center, The Second Hospital of Jilin University","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","article-title":"Helicobacter pylori infection","volume":"9","author":"Malfertheiner","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1111\/liv.15925","article-title":"Relationship between Helicobacter pylori infection and risk of metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis","volume":"44","author":"Mantovani","year":"2024","journal-title":"Liver Int"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global prevalence of Helicobacter pylori infection: systematic review and Meta-analysis","volume":"153","author":"Hooi","year":"2017","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1196338","DOI":"10.3389\/fcimb.2023.1196338","article-title":"Relationship between helicobacter pylori and glycated hemoglobin: a cohort study","volume":"13","author":"Chen","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.dsx.2020.05.009","article-title":"A systematic review and meta-analysis of the prevalence of Helicobacter pylori in patients with diabetes","volume":"14","author":"Mansori","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cld.2007.02.009","article-title":"Epidemiology and natural history of NAFLD and NASH","volume":"11","author":"Ong","year":"2007","journal-title":"Clin Liver Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"8591","DOI":"10.3390\/ijms15058591","article-title":"Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation","volume":"15","author":"Peverill","year":"2014","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jhep.2012.02.027","article-title":"Non-alcoholic fatty liver disease across the spectrum of hypothyroidism","volume":"57","author":"Chung","year":"2012","journal-title":"J Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1186\/s12889-023-16813-2","article-title":"Association between different insulin resistance surrogates and infertility in reproductive-aged females","volume":"23","author":"Xia","year":"2023","journal-title":"BMC Public Health"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1210\/jc.2012-2414","article-title":"Increased fetuin-a concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose","volume":"97","author":"Ou","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2331460","DOI":"10.1080\/19490976.2024.2331460","article-title":"Breaking the barriers: the role of gut homeostasis in metabolic-associated steatotic liver disease (MASLD)","volume":"16","author":"Bened\u00e9-Ubieto","year":"2024","journal-title":"Gut Microbes"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3389\/fmicb.2017.00743","article-title":"The possible role of Helicobacter pylori infection in non-alcoholic fatty liver disease","volume":"8","author":"Cheng","year":"2017","journal-title":"Front Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11894-017-0545-1","article-title":"The association between Helicobacter pylori infection and nonalcoholic fatty liver disease","volume":"19","author":"Tang","year":"2017","journal-title":"Curr Gastroenterol Rep"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2174\/156652409787847191","article-title":"Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines","volume":"9","author":"Polyzos","year":"2009","journal-title":"Curr Mol Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"102563","DOI":"10.3748\/wjg.v31.i13.102563","article-title":"Helicobacter pylori infection is linked to metabolic dysfunction and associated steatotic liver disease: a large cross-sectional study","volume":"31","author":"Ye","year":"2025","journal-title":"World J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"CD012080","DOI":"10.1002\/14651858.CD012080.pub2","article-title":"Non-invasive diagnostic tests for Helicobacter pylori infection","volume":"3","author":"Best","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1086\/315384","article-title":"Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States","volume":"181","author":"Everhart","year":"2000","journal-title":"J Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1017\/S0950268820000126","article-title":"Helicobacter pylori seropositivity is associated with antinuclear antibodies in US adults, NHANES 1999\u20132000","volume":"148","author":"Meier","year":"2020","journal-title":"Epidemiol Infect"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1186\/s40001-023-01536-2","article-title":"Validation of non-invasive indicators in the screening of metabolic dysfunction-associated fatty liver disease: a cross-sectional study among Uighurs in rural Xinjiang","volume":"28","author":"Guo","year":"2023","journal-title":"Eur J Med Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","article-title":"The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018","volume":"23","author":"Dang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"7024","DOI":"10.3748\/wjg.v19.i41.7024","article-title":"Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease","volume":"19","author":"Li","year":"2013","journal-title":"World J Gastroenterol"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1730461\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:34:27Z","timestamp":1782102867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1730461\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":22,"alternative-id":["10.3389\/fnut.2026.1730461"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1730461","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"article-number":"1730461"}}